115
Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D, Jr. Obesi-
ty, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations
for metabolic diversity. J Nutr 2001; 131:354S-360S.
Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis fac-
tor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol
Endocrinol Metab 2001; 280:E745-751.
Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall
Pde L. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and
sex difference studies. J Gastroenterol Hepatol 2003; 18:1272-1282.
Komatsu R, Matsuyama T, Namba M, Watanabe N, Itoh H, Kono N, Tarui S. Glucagonos-
tatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide. Diabetes 1989;
38:902-905.
Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis 2001; 21:89-104.
Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R,
Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa
G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S,
Kadowaki T, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy
and insulin resistance. Mol Cell 1999; 4:597-609.
Kudo H, Yata Y, Takahara T, Kawai K, Nakayama Y, Kanayama M, Oya T, Morita S, Sasahara
M, Mann DA, Sugiyama T. Telmisartan attenuates progression of steatohepatitis in
mice: role of hepatic macrophage infiltration and effects on adipose tissue. Liver Int
2009.
Kurtz TW. Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-
activated receptor-gamma activator. Acta Diabetol 2005; 42 Suppl 1:S9-16.
Kurtz TW. New treatment strategies for patients with hypertension and insulin resistance.
Am J Med 2006; 119:S24-30.
Laclaustra M, Corella D, Ordovas JM. Metabolic syndrome pathophysiology: the role of
adipose tissue. Nutr Metab Cardiovasc Dis 2007; 17:125-139.
Lamont BJ, Drucker DJ. Differential antidiabetic efficacy of incretin agonists versus DPP-4
inhibition in high fat fed mice. Diabetes 2008; 57:190-198.